Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Egypt

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Egypt Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20123
20141
20161
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Novo Nordisk A/S3
Ain Shams University1
Boehringer Ingelheim1
Samar Fares, MD1
Sohag University1
Takeda1
Tanta University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 213
Diabetes Mellitus5
Hyperglycemia4
Acute Coronary Syndrome1
Diabetic Neuropathies1
Glucose Metabolism Disorders1
Inflammation1
Insulin Resistance1
Metabolic Diseases1
Myocardial Infarction1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.